Amgen, Inc. v. United States International Trade Commission, Chugai Pharmaceutical Co., Ltd. And Chugai Pharma U.S.A., Inc., Intervenors

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• noting that the Commission is correct to first assume jurisdiction and then determine merits of claim where patent claims are asserted
• distinguishing Block and recognizing there that the court \found the lack of any findings by the [ITC] to be critical; nothing in the termination [o]rder prejudiced the [ITC] or any private party in a future proceeding\ (emphasis added) (citation omitted)
• distinguishing Block and recognizing there that the court “found the lack of any findings by the [ITC] to be critical; nothing in the termination [o]rder prej- udiced the [ITC] or any private party in a future proceed- ing” (emphasis added) (citation omitted)
• “Dismissals for lack of jurisdiction may be given res judicata effect as to the jurisdictional issue.”

Source: CourtListener parenthetical corpus (CC0).